Search

Your search keyword '"Levy, Donald"' showing total 724 results

Search Constraints

Start Over You searched for: Author "Levy, Donald" Remove constraint Author: "Levy, Donald"
724 results on '"Levy, Donald"'

Search Results

1. Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study

2. Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

6. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

7. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema

13. An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.

16. Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study

20. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

21. Working with Stories: An Active Learning Approach to Theories of Deviance

28. Additional file 4 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

29. Additional file 1 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

30. Additional file 7 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

31. Additional file 1 of Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy

32. Additional file 5 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

33. Additional file 6 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

34. Additional file 2 of Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy

35. Additional file 8 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

36. Additional file 2 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

37. Additional file 3 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

39. Hegemonic complicity, friendship, and comradeship: validation and causal processes among white, middle-class, middle-aged men

42. van der Waals complex and solvatochromism studies of substituted benzenes and naphtalenes

43. Electronic and infrared spectroscopy of anthranilic acid in a supersonic set

45. Electronic spectroscopy and photoisomerization of trans-Urocanic acid in a supersonic jet

47. Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema

49. Supersonic jet spectroscopy and intermolecular electronic energy transfer in naphthalene-(CH2)(subscript n)-anthracene bichromophoric molecules

50. MOESM1 of Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study

Catalog

Books, media, physical & digital resources